Zafar A Shah Selected Research

Zafar A Shah Research Topics

Disease

11	Neoplasms (Cancer) 12/2021 - 05/2009
6	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 12/2010
4	Lung Neoplasms (Lung Cancer) 04/2017 - 06/2012
3	Hypersensitivity (Allergy) 01/2023 - 01/2021
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2021 - 06/2018
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2017 - 11/2014
2	Atopic Dermatitis (Atopic Eczema) 01/2023 - 01/2022
2	Carcinogenesis 01/2022 - 05/2013
2	Asthma (Bronchial Asthma) 01/2021 - 12/2020
2	Adenocarcinoma 10/2017 - 06/2012
2	Carcinoma (Carcinomatosis) 04/2017 - 02/2013
2	Neoplasm Metastasis (Metastasis) 01/2017 - 06/2012
2	Chronic Urticaria 01/2015 - 10/2014
2	Stomach Neoplasms (Stomach Cancer) 06/2014 - 01/2014
2	Infections 06/2014 - 01/2014
2	Inflammation (Inflammations) 06/2014 - 01/2014
1	Vitamin D Deficiency 12/2023
1	Dust Mite Allergy 01/2023
1	Type 2 Diabetes Mellitus (MODY) 05/2022
1	Multiple Sclerosis 05/2022
1	Ovarian Neoplasms (Ovarian Cancer) 09/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Rhinitis 01/2021
1	Acute Promyelocytic Leukemia 01/2019
1	Glioma (Gliomas) 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 07/2017
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2015
1	Arthritis (Polyarthritis) 01/2015
1	Urticaria (Hives) 10/2014
1	Large Cell Carcinoma 06/2012
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2012
1	Prostatic Neoplasms (Prostate Cancer) 09/2010
1	Pleural Tuberculosis 09/2006
1	Tuberculosis (Tuberculoses) 09/2006

Drug/Important Bio-Agent (IBA)

6	Messenger RNA (mRNA)IBA 12/2023 - 06/2012
6	Proteins (Proteins, Gene)FDA Link 12/2023 - 09/2006
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2017 - 06/2012
4	AllergensIBA 01/2023 - 01/2021
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2021
3	Glutathione Transferase (Glutathione S-Transferase)IBA 10/2021 - 09/2010
2	InterleukinsIBA 05/2022 - 10/2014
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022 - 12/2021
2	Tyrosine Kinase InhibitorsIBA 10/2021 - 06/2018
2	EnzymesIBA 10/2021 - 01/2021
2	Imatinib Mesylate (Gleevec)FDA Link 10/2021 - 06/2018
2	Vitamin D FDA LinkGeneric 12/2020 - 01/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2015 - 10/2014
2	DNA (Deoxyribonucleic Acid)IBA 06/2012 - 09/2010
1	Metformin (Glucophage)FDA LinkGeneric 05/2022
1	CationsIBA 05/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Galectin 1 (LGALS1)IBA 09/2021
1	saccharide-binding proteinsIBA 09/2021
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 08/2021
1	TabletsIBA 01/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 12/2020
1	Immunoglobulin E (IgE)IBA 12/2020
1	Interleukin-13IBA 12/2020
1	OxidesIBA 01/2019
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2019
1	ArsenicIBA 01/2019
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2018
1	Alkylating AgentsIBA 01/2018
1	MethyltransferasesIBA 01/2018
1	Temozolomide (Temodar)FDA LinkGeneric 01/2018
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 07/2017
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2016
1	LeptinIBA 01/2015
1	Leptin ReceptorsIBA 01/2015
1	3' Untranslated Regions (3' UTR)IBA 11/2014
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2014
1	CytokinesIBA 10/2014
1	Interleukin-18 (Interleukin 18)IBA 10/2014
1	CarcinogensIBA 06/2014
1	Virulence Factors (Pathogenicity Factors)IBA 06/2014
1	Interleukin-8 (Interleukin 8)IBA 01/2014
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 05/2013
1	RNA (Ribonucleic Acid)IBA 06/2012
1	Oxidoreductases (Dehydrogenase)IBA 08/2011
1	quinone (benzoquinone)IBA 08/2011
1	NAD (NADH)IBA 08/2011
1	NucleotidesIBA 08/2011
1	Proline (L-Proline)FDA Link 12/2010
1	Codon (Codons)IBA 12/2010
1	Environmental CarcinogensIBA 05/2009

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2021 - 01/2018
1	Immunotherapy 01/2022
1	Radiotherapy 01/2018
1	Chemoprevention 11/2014